Aurobindo Pharma Ltd.

NSE: AUROPHARMA | BSE: 524804 | ISIN: INE406A01037 | Industry: Pharmaceuticals
| Mid-range Performer
1167.7000 -5.20 (-0.44%)
NSE Jan 13, 2026 15:31 PM
Volume: 855.0K
 

1167.70
-0.44%
BOB Capital Markets Ltd.
Eugia unit 3 capacity utilization to increase to 60-65% from 50% in Q3FY25. We expect capacity utilisation to rise above 70% in FY26E
Aurobindo Pharma Ltd. has an average target of 1349.22 from 9 brokers.
More from Aurobindo Pharma Ltd.
Recommended